/ Print /

Health/Disease Strategy

Top Non-Healthcare-Related Factors Influencing Patients' Overall HealthA new report from Sage Growth Partners explores how the healthcare a person receives has a very small bearing on their overall health. Here are the other determining factors.
Seven diseases benefiting from genetic tests
Seven diseases benefiting from genetic testsGenetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
What Roche’s Purchase of Flatiron Health Means for Health ExecsSwitzerland-based pharma company Roche’s $1.9 billion purchase of tech company Flatiron Health signifies Big Pharma’s need for data.
Groundbreaking gene therapies in store for hemophiliaTreatment failures can result in a spectrum of problems for patients with hemophilia. Here’s some guidance on choosing the right therapy.
How the Flu’s Severity Will Affect Healthcare SpendingThe flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
Four pain management programs curbing the opioid epidemicFrom State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
Six things to know about CMS' new bundled payment modelCMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Four COPD treatment changes to watchPending and recently approved treatment options for patients with chronic obstructive pulmonary disease range from biologics to a triple-drug inhaler.
Three ways healthcare executives can uncover consumers at risk for fluWith influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
CAR T-cell therapies in treating lymphoma: Pros and consCatherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.